Injectable Drug Delivery Technology Market To Reach USD 2016.83 Billion By 2032, At Growth Rate (CAGR) Of 12.3%
The injectable drug delivery technology market is rapidly expanding, driven by the rising prevalence of chronic diseases like diabetes, cancer, and autoimmune disorders. The growing use of biopharmaceuticals, which often require injection for effective delivery, fuels this growth. Innovations in needle design and delivery systems including autoinjectors, wearable injectors, and needle-free...
0 Σχόλια 0 Μοιράστηκε 52 Views 0 Προεπισκόπηση